BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 20086171)

  • 1. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.
    Dang CV
    Cancer Res; 2010 Feb; 70(3):859-62. PubMed ID: 20086171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
    Dang CV; Le A; Gao P
    Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
    Gao P; Tchernyshyov I; Chang TC; Lee YS; Kita K; Ochi T; Zeller KI; De Marzo AM; Van Eyk JE; Mendell JT; Dang CV
    Nature; 2009 Apr; 458(7239):762-5. PubMed ID: 19219026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC, microRNAs and glutamine addiction in cancers.
    Dang CV
    Cell Cycle; 2009 Oct; 8(20):3243-5. PubMed ID: 19806017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC, metabolism, cell growth, and tumorigenesis.
    Dang CV
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
    Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.
    Dang CV
    Cold Spring Harb Symp Quant Biol; 2011; 76():369-74. PubMed ID: 21960526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MYC in regulation of tumor cell metabolism.
    Wahlström T; Henriksson MA
    Biochim Biophys Acta; 2015 May; 1849(5):563-9. PubMed ID: 25038584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.
    Liu W; Le A; Hancock C; Lane AN; Dang CV; Fan TW; Phang JM
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8983-8. PubMed ID: 22615405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC and tumor metabolism: chicken and egg.
    Dejure FR; Eilers M
    EMBO J; 2017 Dec; 36(23):3409-3420. PubMed ID: 29127156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying Myc's role in metabolism regulation.
    Le A; Dang CV
    Methods Mol Biol; 2013; 1012():213-9. PubMed ID: 24006067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
    Yuneva MO; Fan TW; Allen TD; Higashi RM; Ferraris DV; Tsukamoto T; Matés JM; Alonso FJ; Wang C; Seo Y; Chen X; Bishop JM
    Cell Metab; 2012 Feb; 15(2):157-70. PubMed ID: 22326218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc and cancer metabolism.
    Miller DM; Thomas SD; Islam A; Muench D; Sedoris K
    Clin Cancer Res; 2012 Oct; 18(20):5546-53. PubMed ID: 23071356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancer.
    Anderton B; Camarda R; Balakrishnan S; Balakrishnan A; Kohnz RA; Lim L; Evason KJ; Momcilovic O; Kruttwig K; Huang Q; Xu G; Nomura DK; Goga A
    EMBO Rep; 2017 Apr; 18(4):569-585. PubMed ID: 28219903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of glucose and glutamine utilization by an expanded Myc network.
    Kaadige MR; Elgort MG; Ayer DE
    Transcription; 2010; 1(1):36-40. PubMed ID: 21327161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?
    Dang CV
    Cell Cycle; 2010 Oct; 9(19):3884-6. PubMed ID: 20948290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Time for MYC: Metabolism and Therapy.
    Dang CV
    Cold Spring Harb Symp Quant Biol; 2016; 81():79-83. PubMed ID: 28174256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
    Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
    Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
    Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
    Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.